mebendazole has been researched along with Bright Disease in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kung'u, A | 1 |
1 other study available for mebendazole and Bright Disease
| Article | Year |
|---|---|
Glomerulonephritis following chemotherapy of hydatid disease with mebendazole.
Topics: Adult; Antigen-Antibody Complex; Benzimidazoles; Child; Child, Preschool; Echinococcosis; Female; Gl | 1982 |